Tennessee has become the second state to pass a law allowing pharmaceutical companies to market their products for off-label uses; a House panel advanced legislation that would expand access to private sector care outside of the Veterans Affairs (VA) health system; and nearly half of oncologists recommend medical marijuana to their patients.
Tennessee has become the second state to pass a law allowing pharmaceutical companies to market their products for off-label uses, as long as the information given to doctors is accurate. The law goes into effect July 1 and comes amid rising pressure for the FDA to loosen regulations for off-label use, reported STAT News. Arizona became the first state to enact such legislation last March.Earlier this week, a House panel advanced legislation that would expand the number of veterans who are eligible to see private health specialists and would entitle veterans enrolled in the Veterans Affairs (VA) health system to see a private doctor twice a year without a co-pay, according to The Hill. The reform package, called the VA Mission Act, also includes $5.2 billion to keep the Veterans Choice Program funded until the implementation of the new system.A new survey of 237 oncologists nationwide found that approximately 80% discuss medical marijuana with their patients, NPR reported. Although less than 30% of them feel they have sufficient knowledge to advise them about medical use, nearly half do recommend medical marijuana for their patients. The survey also indicated that the majority of conversations about medical marijuana were initiated by the patient.
2025 Year in Review: Clostridioides difficile Infection
December 12th 2025This year in review of 2025 milestones in Clostridioides difficile infection features coverage of research on infection patterns presented at the American Society for Microbiology Microbe 2025 meeting in June and comparative studies of treatment efficacy and prevention strategies. It also includes an interview with Paul Feuerstadt, MD, on recent developments in C difficile diagnosis and treatment.
Read More